DEFER 发表于 2025-3-25 04:15:15
http://reply.papertrans.cn/83/8285/828464/828464_21.pngARBOR 发表于 2025-3-25 10:56:05
http://reply.papertrans.cn/83/8285/828464/828464_22.pngBarter 发表于 2025-3-25 13:59:57
http://reply.papertrans.cn/83/8285/828464/828464_23.png使尴尬 发表于 2025-3-25 18:07:08
http://reply.papertrans.cn/83/8285/828464/828464_24.png征服 发表于 2025-3-25 23:01:59
http://reply.papertrans.cn/83/8285/828464/828464_25.png出价 发表于 2025-3-26 03:07:55
http://reply.papertrans.cn/83/8285/828464/828464_26.png体贴 发表于 2025-3-26 04:22:39
978-3-319-83438-2Springer International Publishing Switzerland 2016以烟熏消毒 发表于 2025-3-26 09:43:04
Resistance to Tyrosine Kinase Inhibitors978-3-319-46091-8Series ISSN 2196-5501 Series E-ISSN 2196-551X寒冷 发表于 2025-3-26 16:11:07
http://reply.papertrans.cn/83/8285/828464/828464_29.pngInnocence 发表于 2025-3-26 17:04:10
Indications for Tyrosine Kinase Inhibitors in the Treatment of Solid Tumors,nical trials showed survival benefit, setting new treatment indications. Moreover, new molecules are being developed targeting resistance mechanisms such as acquired mutations or feedback mechanisms of the upregulated signaling pathway. The available TKIs and their indications of use through clinical trials are listed and discussed.